Humanwell Healthcare (Group) Co.,Ltd.SSE: 600079

Report for Q1 2026

Apr 30, 2026 · Issued by Humanwell Healthcare (Group) Co.,Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-12

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Humanwell Healthcare (Group) Co.,Ltd. on 6ix

Earlier from Humanwell Healthcare (Group) Co.,Ltd

Announcement on Resolutions of the 7th Meeting of the 11th Board of DirectorsApr 15
Announcement on Obtaining Marketing Authorization from the German Federal Institute for Drugs and Medical Devices (BfArM) for Remifentanil Hydrochloride for InjectionApr 10
Announcement on Convening the 2025 Annual Performance BriefingApr 9
Announcement on Obtaining Drug Registration Certificate by SubsidiaryApr 8
Announcement on Risk Assessment Report for China Merchants Group Finance Co., Ltd.Mar 31

Later from Humanwell Healthcare (Group) Co.,Ltd

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026May 1
Announcement on RFUS-188 Injection Obtaining Notice of Approval for Drug Clinical TrialMay 7
Announcement on Hydrochloride R-Chloroamphetamine Injection Obtaining Notice of Approval for Drug Clinical TrialMay 14
Indicative Announcement on Acceptance of Application for Drug Marketing Authorization of SubsidiaryJun 4
Announcement on Resolutions of the 9th Meeting of the 11th Board of DirectorsJun 5

All Humanwell Healthcare (Group) Co.,Ltd news releases

Follow Humanwell Healthcare (Group) Co.,Ltd into a list and get an email when it puts out news.

Follow Humanwell Healthcare (Group) Co.,Ltd